| Product Code: ETC10536046 | Publication Date: Apr 2025 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Bhawna Singh | No. of Pages: 65 | No. of Figures: 34 | No. of Tables: 19 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Taiwan Ankylosing Spondylitis Market Overview |
3.1 Taiwan Country Macro Economic Indicators |
3.2 Taiwan Ankylosing Spondylitis Market Revenues & Volume, 2021 & 2031F |
3.3 Taiwan Ankylosing Spondylitis Market - Industry Life Cycle |
3.4 Taiwan Ankylosing Spondylitis Market - Porter's Five Forces |
3.5 Taiwan Ankylosing Spondylitis Market Revenues & Volume Share, By Treatment Type, 2021 & 2031F |
3.6 Taiwan Ankylosing Spondylitis Market Revenues & Volume Share, By Application, 2021 & 2031F |
3.7 Taiwan Ankylosing Spondylitis Market Revenues & Volume Share, By End User, 2021 & 2031F |
4 Taiwan Ankylosing Spondylitis Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing awareness and diagnosis rates of ankylosing spondylitis in Taiwan |
4.2.2 Growing research and development activities for new treatments and therapies |
4.2.3 Rising healthcare expenditure and government initiatives to improve access to healthcare services |
4.3 Market Restraints |
4.3.1 High treatment costs and limited insurance coverage for ankylosing spondylitis medications |
4.3.2 Lack of skilled healthcare professionals specializing in ankylosing spondylitis management |
4.3.3 Stringent regulatory requirements for the approval of new treatments in Taiwan |
5 Taiwan Ankylosing Spondylitis Market Trends |
6 Taiwan Ankylosing Spondylitis Market, By Types |
6.1 Taiwan Ankylosing Spondylitis Market, By Treatment Type |
6.1.1 Overview and Analysis |
6.1.2 Taiwan Ankylosing Spondylitis Market Revenues & Volume, By Treatment Type, 2021 - 2031F |
6.1.3 Taiwan Ankylosing Spondylitis Market Revenues & Volume, By NSAIDs, 2021 - 2031F |
6.1.4 Taiwan Ankylosing Spondylitis Market Revenues & Volume, By Biologic Drugs, 2021 - 2031F |
6.1.5 Taiwan Ankylosing Spondylitis Market Revenues & Volume, By Physical Therapy, 2021 - 2031F |
6.1.6 Taiwan Ankylosing Spondylitis Market Revenues & Volume, By Surgery, 2021 - 2031F |
6.2 Taiwan Ankylosing Spondylitis Market, By Application |
6.2.1 Overview and Analysis |
6.2.2 Taiwan Ankylosing Spondylitis Market Revenues & Volume, By Pain & Inflammation, 2021 - 2031F |
6.2.3 Taiwan Ankylosing Spondylitis Market Revenues & Volume, By Disease Management, 2021 - 2031F |
6.2.4 Taiwan Ankylosing Spondylitis Market Revenues & Volume, By Mobility Improvement, 2021 - 2031F |
6.2.5 Taiwan Ankylosing Spondylitis Market Revenues & Volume, By Severe Cases Treatment, 2021 - 2031F |
6.3 Taiwan Ankylosing Spondylitis Market, By End User |
6.3.1 Overview and Analysis |
6.3.2 Taiwan Ankylosing Spondylitis Market Revenues & Volume, By Hospitals, 2021 - 2031F |
6.3.3 Taiwan Ankylosing Spondylitis Market Revenues & Volume, By Clinics, 2021 - 2031F |
6.3.4 Taiwan Ankylosing Spondylitis Market Revenues & Volume, By Rehabilitation Centers, 2021 - 2031F |
6.3.5 Taiwan Ankylosing Spondylitis Market Revenues & Volume, By Specialty Clinics, 2021 - 2031F |
7 Taiwan Ankylosing Spondylitis Market Import-Export Trade Statistics |
7.1 Taiwan Ankylosing Spondylitis Market Export to Major Countries |
7.2 Taiwan Ankylosing Spondylitis Market Imports from Major Countries |
8 Taiwan Ankylosing Spondylitis Market Key Performance Indicators |
8.1 Average time from symptom onset to diagnosis of ankylosing spondylitis |
8.2 Patient adherence rates to prescribed treatment regimens |
8.3 Number of clinical trials for ankylosing spondylitis therapies in Taiwan |
8.4 Patient-reported outcomes measures related to quality of life and disease management |
8.5 Percentage of healthcare facilities offering specialized care for ankylosing spondylitis |
9 Taiwan Ankylosing Spondylitis Market - Opportunity Assessment |
9.1 Taiwan Ankylosing Spondylitis Market Opportunity Assessment, By Treatment Type, 2021 & 2031F |
9.2 Taiwan Ankylosing Spondylitis Market Opportunity Assessment, By Application, 2021 & 2031F |
9.3 Taiwan Ankylosing Spondylitis Market Opportunity Assessment, By End User, 2021 & 2031F |
10 Taiwan Ankylosing Spondylitis Market - Competitive Landscape |
10.1 Taiwan Ankylosing Spondylitis Market Revenue Share, By Companies, 2024 |
10.2 Taiwan Ankylosing Spondylitis Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |